Honorary Chair
Stephen Kwok-Wing Tsui, Professor, The Chinese University of Hong Kong, Hong Kong, China
Scientific Committee Members
Adel K. El-Naggar, Professor and Section Chief, Head and Neck Pathology, MD Anderson Cancer Center, The University of Texas, USA
Alfred Sze-Lok Cheng, Professor, The Chinese University of Hong Kong, Hong Kong, China
Catherine K. L. Too, Professor, Dalhousie University; Senior Scientist, Beatrice-Hunter Cancer Research Institute, Canada
Cong Yan, Professor of Pathology and Laboratory Medicine, Indiana University School of Medicine, USA
David I Smith, Professor and Consultant, the Department of Laboratory Medicine and Pathology; Chairman, the Technology Assessment Group, Mayo Clinic, USA
Edward B. Silberstein, Emeritus Professor, University of Cincinnati Medical Center, USA
Gennaro Ciliberto, Scientific Director, Regina Elena National Cancer Institute, Italy
Giulia Adriani, Principal Investigator, Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR); Adjunct Assistant Professor, National University of Singapore, Singapore
Hans-Joachim Schmoll, Professor, University Clinic, Martin Luther University, Halle (Saale), Germany
Jeffrey W. Sherman, CMO and EVP, Horizon Pharma, Inc., Ireland
John Greenman, Professor of Tumour Immunology, University of Hull, UK
John H. Shin, Assistant Professor, Director of Metastatic Spine Oncology and Spinal Deformity Surgery, Massachusetts General Hospital, USA
Martin C.S. Wong, Professor, The Chinese University of Hong Kong, Hongkong China
Olusola O Faluyi, Consultant Medical Oncologist, The Clatterbridge Cancer Centre NHS Foundation Trust, UK
Qihui (Jim) Zhai, Professor and Pathologist, Mayo Clinic, USA
Suresh Srivastava, President, ChemGenes Corporation, USA
Tadeusz Robak, Professor, Medical University of Lodz, Poland
Valerio Gennaro, Head of Liguria Mesothelioma Registry, IRCCS Ospedale Policlinico San Martino, Italy
Xiaohui Xu, Department Head and Associate Professor, Department of Epidemiology and Biostatistics, School of Public Health, Texas A&M University, USA
Yibin Feng, Associate Professor, Associate Director (Education), School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Few Ling Ling, Associate Professor, School of Health Sciences,Health Campus, University of Science Malaysia, Malaysia
Karen Xie, Assistant Professor, Department of Radiology, University of Illinois Hospital and College of Medicine, USA
Zorka Inic, General Surgeon, Institute for Oncology and Radiology of Serbia, Serbia
Johannes Schweizer, Chief Science Officer, Arbor Vita Corporation, USA
Sawsan A.S. Al Madhi, Director General, Friends of Cancer Patients (FOCP), the United Arab Emirates
Liang Wang, Professor, Attending Radiologist, Vice-Chairman for the Clinical Affairs, Director of Abdominal & Pelvic Imaging-Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
Huamin Wang, Professor, The University of Texas MD Anderson Cancer Center, USA
Session Chairs
Session 1: Cancer Molecular Biology & Genetics (Part I)
Chair: Catherine Too, Professor, Dalhousie University, Canada
Co-Chair: Aleksi Sedo, Dean of the 1st Faculty of Medicine, Charles University in Prague, Czech Republic
Session 2: Liver, Cholecyst and Pancreatic Cancer
Chair: Yibin Feng, Associate Professor, Associate Director (Education), School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Co-Chair: Huamin Wang, Professor, The University of Texas MD Anderson Cancer Center, USA
Session 3: Cancer Immunology & Immunotherapy (Part I)
Chair: Giulia Adriani, Principal Investigator, Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR); Adjunct Assistant Professor, National University of Singapore, Singapore
Session 4: Cancer Prevention and Epidemiology
Chair: Pauline E Jolly, Professor, University of Alabama at Birmingham, USA
Session 5: Cancer Pharmacology
Chair: Marco Falasca, Professor of Metabolism, School of Pharmacy and Biomedical Sciences, Curtin University, Australia
Co-Chair: Hongtao Xiao, Professor, University of Electronic Science and Technology of China, China
Session 6: Cancer Screening & Diagnosis (Part I)
Chair: Masahiro Iwata, Director, Department of Maxillofacial Surgery, Uji Tokushukai Medical Center, Japan
Co-Chair: Hua Yang, Clinical Associate Professor and the Breast Pathology Specialty Group Leader, University of Calgary, Canada
Session 7: Cancer Metastasis
Chair: Grace Tan, Consultant, National Cancer Centre Singapore, Singapore
Co-Chair: John Ionescu, Associate Professor and Director, Special Clinic Neukirchen, Germany
Session 8: Cancer Precision Medicine
Chair: Ryan S. Robetorye, Consultant and Medical Director of Clinical Laboratories; Director, Coagulation Laboratory; Co-Director, Molecular Diagnostics Laboratory; Director, Next-Generation Sequencing Laboratory, Mayo Clinic in Arizona, USA
Co-Chair: Ziyan Y. Pessetto, Clinical Associate Professor and Assistant Director, Clinical Molecular Oncology Laboratory; Co-Director, COBRE Kansas Institute for Precision Medicine University of Kansas Medical Center, USA
Session 9: Cancer Screening & Diagnosis (Part II)
Chair: Min-Ying Lydia Su, Professor and Director, Tu & Yuen Center for Functional Onco-Imaging, Department of Radiological Sciences, University of California, Irvine, USA
Session 10: Cancer Biomarkers
Chair: Valery V. Khramtsov, Professor and Director, In Vivo Multifunctional Magnetic Resonance Center, West Virginia University, USA
Session 11: Anti-Cancer Drug Discovery & Development
Chair: Nicholas D. P. Cosford, Deputy Director and Professor, NCI-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, USA
Session 12: Gastrointestinal Cancer
Chair: Asif Rashid, Professor, The University of Texas MD Anderson Cancer Center, USA
Co-Chair: Ming Teh, Senior Consultant, National University Hospital, Singapore
Session 13: Genitourinary Cancer
Chair: Xiaohui Xu, Department Head and Associate Professor, Department of Epidemiology and Biostatistics, School of Public Health, Texas A&M University, USA
Co-Chair: Charles Guo, Professor, The University of Texas MD Anderson Cancer Center, USA
Session 14: Cancer Molecular Biology & Genetics(Part II)
Chair: Yanping Zhang, Professor, The University of North Carolina at Chapel Hill, USA
Co-chair:Stephen Kwok-Wing Tsui, Professor, The Chinese University of Hong Kong, Hong Kong, China
Session 15: Gynecologic Cancer
Chair: Amnon Amit, Director, Gyneco-Oncology Unit, Rambam Health Care Campus, Israel
Co-Chair: Peter A. van Dam, Head Division of Gynecologic Oncology, Antwerp University Hospital and University of Antwerp, Belgium
Session 16: Head & Neck Cancer
Chair: Wei-liang Chen, Director, Professor and Chief Surgeon, Department of Oral and Maxillofacial Surgery, Sun Yat-Sen Memorial Hospital of Sun Yat-sen University, China
Co-Chair: Vivian Wai Yan Lui, Associate Professor, The Chinese University of Hong Kong, Hong Kong, China
Session 17: Breast Cancer
Chair: Valerie C. L. Lin, Associate Professor, Nanyang Technological University, Singapore
Session 18: Cancer Molecular Biology & Genetics (Part III)
Chair: Udayan Guha, Head, Cancer Signaling Networks Section; Investigator, Thoracic and GI Malignancies Branch, National Cancer Institute, National Institutes of Health,USA
Co-Chair: Dehui Xu, Associate Professor, Xi'an Jiaotong University, China
Session 19: Breast Cancer (Part II)
Chair: Clement Chia, Consultant, Khoo Teck Puat Hospital, Singapore
Co-chair: Michael N. Liebman, Managing Director, IPQ Analytics, LLC Inc; Professor, Drexel College of Medicine, USA
Session 20: Lung Cancer
Chair: Wickii Thambiah Vigneswaran, Professor and Director of Thoracic Surgery, Loyola University Health System, USA
Co-Chair: Baohui Han, Professor and Director of Pulmonary Medicine Department, Shanghai Chest Hospital, China
Session 21: Melanoma/Skin Cancers
Chair: Yanlin Yu, Staff Scientist, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA
Session 22: Blood and Lymphatic Cancers
Chair: Ben C. Valdez, Associate Professor, The University of Texas MD Anderson Cancer Center, USA
Session 23: Pediatric Oncology
Zhaoming Wang, Associate Member, Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, USA
Session 24: Radiation and Medical Oncology
Chair: Alexander Muacevic, Neurosurgeon/Radiosurgeon, Professor and Director, Cyberknife Center Munich, University of Munich Hospitals, Germany
Co-Chair: Val J. Lowe, Director, Mayo Clinic Molecular Imaging Core; Director, Nuclear Medicine Research; Professor, Mayo Clinic, Rochester, USA
Session 25: Robotic and AI in Surgical Oncology
Chair: Mathew Thomas, Assistant Professor and Director of Thoracic Surgery, Mayo Clinic, Jacksonville, Florida, USA
Co-Chair: Renaud Garrel, Professor and Head of Head Neck Cancer & Laryngology Team, Montpellier University Hospital Center, France
Session 26: Cancer Immunology & Immunotherapy (Part II)
Chair: Tapan K Bera, Senior Associate Scientist, National Cancer Institute, National Institute of Health, USA
Co-Chair: Sai-Ching Jim Yeung, Professor and Director of Research, The University of Texas MD Anderson Cancer Center, USA
Poster Session
Chair: Veronika Talianová, PhD Student, 1st Faculty of Medicine, Charles University in Prague, Czech Republic
Session Chairs
Hosting Organization
International Science and Technology Conference Institute
Operating Organization
FLC Event Co., Ltd.
Supporting Organization
Sino Elite Consultants Pte. Ltd.
|